28th Mar 2006 16:00
AstraZeneca PLC28 March 2006 Dealing by DirectorsCompanies Act 1985 Sections 324/329 We hereby inform you that on 24 March 2006 the following Directors ofAstraZeneca PLC were granted options under the AstraZeneca Share Option Planover the Company's USD0.25 Ordinary Shares. Number of shares Exercise Period when Total number over which option price per exercisable of shares Name of Director is granted share under option D R Brennan 87,731 2975p 24.3.09-23.3.16 See below J R Symonds 50,862 2975p 24.3.09-23.3.16 363,420 J S Patterson 41,552 2975p 24.3.09-23.3.16 238,187 The options will become exercisable on 24 March 2009 subject to certainperformance conditions. The conditions, which will not be subject to anyretesting, are that the earnings per share of the Company must increase by theincrease in the UK Retail Prices Index plus 5% per annum on average over threeyears, and that no significant unforeseen event has taken place which, in thereasonable opinion of the Remuneration Committee, has resulted in majorreputational damage to AstraZeneca, and the circumstances of which areexceptional enough to justify the option not vesting and becoming exercisable.Failure to satisfy either or both of these conditions will result in the lapseof the option in its entirety. David R Brennan, a Director of the Company, has previously received grants ofoptions over the Company's American Depositary Shares (ADSs). One ADS equalsone Ordinary Share. Following the grant of options referred to above, DavidBrennan has options over 87,731 Ordinary Shares and 440,643 ADSs. G H R MuskerCompany Secretary28 March 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Astrazeneca